Woman Injured by J&J Vaccine Has ‘Never Seen Such

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
366
Woman Injured by J&J Vaccine Has ‘Never Seen Such Meanness’

After she was injured by the Johnson & Johnson COVID-19 vaccine, Sheila Bath said doctors screamed at her and told her she was “nuts” for thinking the vaccine caused her injuries.


Sheila Bath, a 60-something chef and life coach from Connecticut, first suspected she’d been injured by the single-dose Johnson & Johnson (J&J) COVID-19 vaccine on April 11, 2021 — exactly 14 days after she got the vaccine.

In an exclusive interview with The Defender, Bath said her initial symptoms included a burning sensation running from her legs to her spine and numbness in her feet. The symptoms lasted for two months.

“My legs were burning from my ankle all the way up to my lower spine on both sides. Burning, burning, burning,” Bath said. “My feet were numb. It was burning out the nerves in my legs and in my spine.”

She said she also sustained “terrible bruising” on her extremities, dry mouth, worsening vision, inability to walk, cysts on her kidneys, gallstones in her bladder, calf cramps, muscle spasms, depression, brain fog and 20 lbs. of water-weight gain.

These are “classical Guillain-Barré Syndrome symptoms,” Beth said.

Bath suspected the vaccine triggered the symptoms, but doctors were initially reluctant to draw the same conclusion.

Bath told The Defender:

“I didn’t know what Guillain-Barré was, but it’s a very well-known thing that you have to go directly to the hospital. And my neurologist could have sent me directly to the hospital. The neurologist neglected to follow the protocol of getting me into hospital when they could have cured it.”

“Three times I went back to him and he sent me home,” she said, telling her, “There’s nothing wrong with you. You’ve got neuropathy because you’re older.”

When Bath told her doctor the only explanation she could think of was that she’d been vaccinated two-and-a-half weeks ago, “He practically kicked me out of the office,” she said. “And then I called back a third time. I said, my legs are still burning up … can you help me? And they refused to see me.”

Then things got worse.

More than a year after getting the J&J vaccine, Bath began to experience new symptoms, including partial digestive paralysis, which she said “means the COVID-19 spike protein was still alive, doing damage,” even though it is “supposed to be a dead virus, we were told.”

Doctors attributed the new symptoms to Crohn’s disease, a type of inflammatory bowel disorder, because Bath had a history of autoimmune disease.

But Bath disagreed with that diagnosis:

“I felt like saying, honey, I had Crohn’s when nobody knew Crohn’s, and I had to fight my way through that for 13 years. I said, that is not Crohn’s … That is the paralysis from the shot.”

Bath described being “chided and yelled at” by doctors for even suggesting her health troubles were related to the vaccine. According to her, it was not until she visited a naturopathic doctor that she finally received care, attention and a concrete diagnosis.

She said:

“I walked in, he took one look at me and he said, ‘I know what you got.’ The first time I saw him, he says, ‘you’ve got paralysis in your spine and in your legs. Did you take the Johnson & Johnson vaccine or what other one?’

“He said, ‘I’ve got an antidote for that, a homeopathic antidote for peristalsis.’ And sure enough, it worked. Now, did it work perfectly? No. But what it did do was save my life.”


According to Bath, when she shared the news of this successful treatment with her cardiologist, “She started screaming at me, this nice, gentle woman who isn’t even connected to the vaccine.”

Bath was initially reluctant to get a COVID-19 vaccine, she said, but was required to get it for employment reasons.

She opted to receive the single-dose J&J vaccine because, “I figured, well, one [dose] is better than two.”

Although Bath acknowledged there was information available advising people with autoimmune conditions to avoid the J&J vaccine, she said she was “in remission for 20 years through natural means.”

But she also believes she wouldn’t necessarily have been better off getting the Pfizer or some other COVID-19 vaccine.

“Who knows? If I was pressured into taking the Pfizer [vaccine], maybe I would have been worse off,” Bath said.

Bath also noted that the specific J&J dose she received came from the Baltimore Emergent BioSolutions manufacturing plant that subsequently was shut down after reports of regulatory problems.

The injuries and adverse effects Bath sustained have been debilitating in terms of her ability to work.

Bath told The Defender:

“I used to work 10-12 hours a day. I have not been able to work in 16 months. My neurologist also refused disability, [putting] me into poverty.

“My greatest fear is being homeless. I’ve happily worked my whole life, never asked for help … I was crying every day and definitely suicidal … I haven’t been able to work and [this experience] totally put me into poverty. I’ve been very close to homelessness a few times … I ran through all my money.”

Fortunately, she said, she discovered the Vaccine Injury/Side Effects Support Group, featured last month by The Defender.

Bath said membership in the support group resulted in her “confirming that I was not alone, and that doctors were purposely lying, all over the world,” adding, “Thank God for Catherine’s group,” referring to its founder, Catherine Parker, who also was injured by the J&J vaccine.

“We all share information, symptom, and information on what is helping us,” said Bath, referring to her interactions with other members of the support group.

According to Bath, seeing the large number of participants in such groups and interacting with them has “broken my heart,” but at the same time, has provided a degree of comfort, “knowing that I’m not out of my mind.

“Doctors tell me I’m nuts,” said Bath. “I’ve never seen such meanness in my life,” adding, “You know, friends disappear, family disappears. So thank God for these groups, but I wish they weren’t necessary.”

The support group faces challenges, however, according to Bath — namely, attempted censorship by Facebook, where the group is hosted.

“The fact that we’re connecting — they keep trying to knock us off,” said Bath.

Bath told The Defender that prior to her injuries, she was planning for a new phase in her life — life coaching.

“Helping people, helping prevent Crohn’s disease, helping prevent food poisoning … I already had it set up … and I’d have a full life. It was planned out … I loved every bit of what I was doing.”

Her injuries have delayed but not ended her plan. She told The Defender she has completed a life coach trauma healing certification, adding:

“My assignment is helping people get as better as possible, and I’m getting that extra certification for trauma because we’ve all been traumatized for the last five or six years.

“And to add to that … my two majors now are helping people with Crohn’s disease, but mostly with the vaccine injuries … those are my two goals.”

Through this, Bath hopes that she can sensitize the broader public to what is happening.

“We need the public to know this is not political,” Bath said. “Both sides of the aisle have been hurt, and we are in this together.

She added: “We can’t trust the regulators because they’re all owned by Yale and Harvard and everything else.”

https://childrenshealthdefense.org/defender/s...e5016fd5f8
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epsilor Launches Cutting-Edge 6T Battery for Military Use

Updated Category News Views 1

A Big Leap for Military Power on the Go Seems like Epsilor just raised the stakes in the military tech race with their latest 6T battery, a piece of kit boasting some serious muscle at 4,400Wh with 174Ah thrown in for good measure. Serving up a military-grade solution where endurance and performance are necessities, they've entered production just in time for the...

Continue Reading
STANLEY Dives Into Flooring: Strategic Move or Risky Bet?

Updated Category News Views 3

STANLEY® Floors: The New Frontier? Who would've thought STANLEY®, the tool giant founded back in 1843, would dive headfirst into the flooring market? This isn’t just any leap; it's a strategic handshake with Area Floors, and they’re dragging along i4F’s renowned drop-lock tech for good measure. What does this mean for the flooring landscape and STANLEY's brand...

Continue Reading
Vanda Pharmaceuticals Steps Into September Investor Talks

Updated Category News Views 2

Vanda Pharmaceuticals Heads Into Key Investor Spotlights In the relentless quest for market edge, Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is setting the stage for what could be some telling moments in September 2026. Investors with a keen interest in the pharmaceutical realm should seat themselves upfront as Vanda takes the floor in a series of pivotal conferences. Each...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 1

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading
Epson and STOPware Reinvent Visitor Badges for Security

Updated Category News Views 12

Gone are the days when a flimsy monochrome badge was all that stood between a visitor and unrestricted access. Today, Epson and STOPware rock the boat with their new collaboration, offering a game-changing approach to security with full-color badge printing. This isn't just a vanity upgrade; it's about real security enhancement creating immediate visual cues. Shifting the...

Continue Reading
Corgi Re Modernizes Reinsurance with Tech-Focus

Updated Category News Views 2

Amidst the hullabaloo of the reinsurance world, Corgi Insurance is attempting something rather bold. They're flinging open the doors to innovation with a new brainchild, Corgi Re, promising to shake off the dust from an industry that still clings to the bygone era of spreadsheets and marathon underwriting cycles. The aim? Fire up modern underwriting technology and...

Continue Reading
Tolnai Joins UPCEA Leaders Pioneering Credential Innovations

Updated Category News Views 1

The Future of Education Shaped Today There's a profound shift happening in higher education, and it's not the usual undergrad grind most folks think of. Cate Tolnai, stepping into her role at the University of Phoenix, is in the thick of it. She's set to join the UPCEA Council for Credential Innovation's leadership team, and that isn't some fluff title. Her appointment...

Continue Reading
Mega Matrix Shares Consolidation Ahead: What It Means

Updated Category News Views 1

Quick and Unexpected Moves at Mega Matrix Just when you thought things couldn't get more complicated in the world of Mega Matrix Inc. (NYSE: MPU), they pull a rabbit out of the hat at their Extraordinary General Meeting on September 1st. Held at their office in Singapore, shareholders green-lighted some heavy-hitting changes like a share consolidation—twenty into one...

Continue Reading
Check Point Shareholders Back 2026 AGM Proposals

Updated Category News Views 0

Shareholder Endorsement Solidifies Check Point's Strategy Today, Check Point Software Technologies had a bit of a celebratory mood. Their stakeholders, it seems, aren't just riding the wave; they're all in. You could almost hear the cheers from Redwood City when those shareholder voting results flashed across the board. Some 81.2 million shares—encompassing about 79.52%...

Continue Reading
Costa Rica's Summit Draws Global Investors, Buyers

Updated Category News Views 0

Costa Rica's Big Stage for Business and Opportunity You might look at Costa Rica and think of lush rainforests and coffee beans, but right now, it's a hub bustling with suits, spreadsheets, and strategic meetings. Over three days, the Costa Rica Trade & Investment Summit (CRTIS) gathered nearly half a thousand buyers and investors all under one roof in San José. Local...

Continue Reading

Top 5 Most Recently Viewed Articles

BlackRock Moves Past 3% Stake in Syensqo, Notifications Issued

Updated Category News Views 186

BlackRock Inc. Participation Notification for Syensqo In a noteworthy development, BlackRock Inc. has recently communicated to Syensqo its participation status under Belgian transparency regulations, signaling a significant movement in their share ownership. The company has crossed the crucial 3% threshold, which triggers a notification requirement. Here’s a...

Continue Reading
Exploring the Bullish Trends in D-Wave Quantum's Options Trades

Updated Category News Views 262

Understanding D-Wave Quantum's Options Activity Recently, notable investors have exhibited a strong bullish sentiment towards D-Wave Quantum, signaling confidence in its future performance. When analyzing the options history for D-Wave Quantum (NYSE: QBTS), we identified a total of 21 trades. This activity reveals the mindset of investors which could be crucial for future...

Continue Reading
ECN Capital Moves Forward with Share Buyback Initiatives

Updated Category News Views 67

ECN Capital's Strategic Buyback Plans Approved ECN Capital Corp. (TSX: ECN) has recently received approval from the Toronto Stock Exchange (TSX) to begin normal course issuer bids for its common shares and Series C preferred shares. This strategic decision is aimed at effectively managing the company's equity structure while optimizing its cash resources. Understanding...

Continue Reading
Understanding Recent Updates on Cellectis Voting Rights

Updated Category News Views 130

Significant Updates on Cellectis Share Capital Cellectis is currently navigating through exciting timelines that focus on share capital and voting rights. As a prominent player in the gene editing industry, the company strives diligently to engage with its shareholders and keep them informed about the specifics of its capital structure. Market Listing and Share Details...

Continue Reading
Mallinckrodt plc Reports Strong Q3 Performance and Upgraded Guidance

Updated Category News Views 36

Mallinckrodt plc Financial Highlights Mallinckrodt plc, a global leader in specialty pharmaceuticals, has recently announced its financial outcome for the third quarter of the current fiscal year, demonstrating continued resilience and growth. With net sales reaching $505.5 million, marking a 1.7% increase compared to the same quarter last year, the company has reaffirmed...

Continue Reading